MarketResearchReprots.com has announced the addition of “Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2018” research report to their website www.MarketResearchReports.com

Lewes, DE -- (SBWire) -- 12/11/2018 --Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2018'; Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target constitutes close to 30 molecules. Out of which approximately 27 molecules are developed by companies and remaining by the universities/institutes.

Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Soluble guanylyl cyclase (sGC) is the known receptor for nitric oxide. Binding of nitric oxide to the heme moiety of the cyclase induces its capacity to synthesize the second messenger cGMP. Although the changes in the state of the heme moiety upon exposure of enzyme to NO and its correlation to the stimulation of sGC catalytic activity.

The report 'Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2018' outlays comprehensive information on the Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are 3, 6, 3 and 15 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively.

Report covers products from therapy areas Ophthalmology, Cardiovascular, Metabolic Disorders, Respiratory, Central Nervous System, Gastrointestinal, Hematological Disorders, Immunology, Infectious Disease, Oncology, Dermatology, Genetic Disorders, Genito Urinary System And Sex Hormones and Toxicology which include indications Glaucoma, Ocular Hypertension, Diabetic Nephropathy, Open-Angle Glaucoma, Pulmonary Hypertension, Sickle Cell Disease, Tinea Pedis (Athlete Foot), Acute Respiratory Distress Syndrome, Alzheimer's Disease, Carotid Artery Stenosis, Chemotherapy Induced Peripheral Neuropathy, Chronic Kidney Disease (Chronic Renal Failure), Cystic Fibrosis, Diabetic Foot Ulcers, Diabetic Neuropathic Pain, Diastolic Heart Failure, Duchenne Muscular Dystrophy, Esophageal Achalasia, Inflammation, Ischemic Stroke, Liver Diseases, Lung Disease, Mycobacterium Infections, Onychomycosis (Tinea Unguium), Optic Neuropathy, Osteoporosis, Pancreatic Cancer, Prostate Cancer, Pulmonary Arterial Hypertension, Stroke, Systemic Sclerosis (Scleroderma), Systolic Heart Failure, Vascular Dementias and Wounds.

Scope
- The report provides a snapshot of the global therapeutic landscape for Soluble Guanylate Cyclase (sGC or EC 4.6.1.2)
- The report reviews Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics and enlists all their major and minor projects
- The report assesses Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics

Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Soluble Guanylate Cyclase (sGC or EC 4.6.1.2)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Spanning over 93 pages "Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2018" report covers Introduction, Report Coverage, Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Overview, Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Therapeutics Development, Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Therapeutics Assessment, Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Companies Involved in Therapeutics Development, Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drug Profiles, Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Dormant Products, Appendix. This report Covered Companies - Bayer AG, Boehringer Ingelheim GmbH, Ironwood Pharmaceuticals Inc, NicOx SA, Novan Inc, Novartis AG, SynZyme Technologies LLC, Topadur Pharma AG.

Please visit this link for more details: https://www.marketresearchreports.com/global-markets-direct/soluble-guanylate-cyclase-sgc-or-ec-4612-pipeline-review-h2-2018

Find all Drug Pipeline Reports at: https://www.marketresearchreports.com/drug-pipeline

For related reports please visit: https://www.marketresearchreports.com/search/site/Soluble%2520Guanylate%2520Cyclase

Read our Interactive Market Research Blog

About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements: https://www.marketresearchreports.com/contact